Treatment of thromBocytopenia With EltRombopag or Intravenous Immune Globulin (IVIG) Before and DurING Invasive Procedures in Patients With Immune ThrombocytoPenia- BRIDGING ITP Study
Status: Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 14 Aug 2019
Price : $35 *
At a glance
- Drugs Eltrombopag (Primary) ; Immune globulin
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- Acronyms BRIDGING ITP
- 12 Aug 2019 Planned End Date changed from 1 Sep 2019 to 1 Dec 2019.
- 07 Mar 2019 Planned End Date changed from 1 Jan 2019 to 1 Sep 2019.
- 07 Mar 2019 Planned primary completion date changed from 1 Jan 2019 to 1 Jun 2019.